Business Context and Reporting Period
Company: IPERIONX Ltd (IPX)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal Year ended June 30, 2025
Business Overview: IperionX is an Australian corporation transitioning into a commercial producer of titanium metal products in the United States. The company utilizes patented technologies (HAMR™, HSPT™) to produce high-performance titanium alloys from minerals or scrap at lower energy costs and carbon emissions compared to the traditional Kroll process. Operations are centered at the Titanium Manufacturing Campus in Virginia, with exploration activities at the Titan Project in Tennessee.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Revenue | Not explicitly stated as a line item; primarily government grants and reimbursements. | Not explicitly stated as a line item. |
| Net Loss | $(35.3) million | $(21.8) million |
| Operating Cash Flow | $(21.8) million (Used) | $(18.6) million (Used) |
| Investing Cash Flow | $(24.3) million (Used) | $(6.5) million (Used) |
| Financing Cash Flow | $68.0 million (Provided) | $46.6 million (Provided) |
| Cash and Cash Equivalents (End of Period) | $54.8 million | $33.2 million |
| Total Assets | $105.0 million | $55.4 million |
| Total Liabilities | $12.6 million | $4.1 million |
| Net Assets (Equity) | $92.4 million | $51.3 million |
| Capital Expenditures | $17.6 million | $8.1 million |
Note: The filing does not provide a specific "Revenue" line item for product sales. Income is derived primarily from government grants (DoW) and finance income (interest and FX gains).
Material Changes vs. Prior Period
- Increased Losses: Net loss increased by $13.5 million (62%) to $35.3 million, driven by higher R&D expenses ($12.7M vs $8.7M), corporate/admin expenses ($10.7M vs $4.5M), and share-based payment expenses ($9.6M vs $3.8M).
- Capital Expansion: Investing cash outflows increased significantly to $24.3 million, reflecting the purchase of property, plant, and equipment ($17.0M) and intangible assets ($6.7M) to scale the Virginia facility.
- Government Funding: The company received $5.6 million in cash reimbursements from the U.S. Department of War (DoW) under the DPA Title III program and recognized $0.9 million in grant income under the IBAS program.
- Production Milestones: Commissioning of the Titanium Production Facility (TPF) in Virginia was completed. Nameplate capacity increased from 125 tpa to 200 tpa through process improvements without additional capex.
- Equity Financing: Proceeds from share issuances increased to $71.1 million in 2025 compared to $48.3 million in 2024.
Guidance, Outlook, and Risks
Outlook and Guidance
- Scale-Up Targets: Plans to scale titanium production to 1,400 metric tons per year (tpa) by 2027 and target over 10,000 tpa of high-performance components by 2030.
- Commercialization: The company expects to continue incurring net losses until commercial-scale production ramps up. It has secured a $11 million sourcing contract with Ford Motor Company and a $1.3 million task order from the U.S. Army.
- Capital Requirements: Significant additional funding will be required to expand the Titanium Manufacturing Campus and develop the Titan Project. The company relies on equity financing, debt, and government grants.
Risks and Contingencies
- Government Asset Title: Equipment acquired with federal funds (approx. $10.3M as of June 30, 2025) is titled to the U.S. government. Title transfer to IperionX is not guaranteed and depends on satisfactory performance by the agreement termination date (Jan 30, 2027).
- Going Concern: While substantial doubt about going concern was alleviated in September 2025 due to a subsequent capital raise ($46M) and strong cash position, the company remains dependent on future financing.
- Regulatory and Permitting: The Titan Project is in the exploration stage with no defined reserves. Development requires significant permitting, which is subject to delays and regulatory changes.
- Internal Controls: Material weaknesses in internal controls identified in prior years were remediated as of June 30, 2025.
Investor Verification Checklist
- Government Funding Terms: Verify the specific conditions for the transfer of title on the $10.3M of government-owned assets and the timeline for the remaining $47.1M IBAS award obligations.
- Revenue Recognition: Confirm the timing and magnitude of revenue recognition from the Ford Motor Company contract and U.S. Army task orders, as current financials show minimal commercial revenue.
- Cash Burn Rate: Assess the sustainability of the $54.8M cash balance against the projected capital expenditures required to reach the 1,400 tpa scale-up target by 2027.
- Titan Project Feasibility: Review the progress of the definitive feasibility study (expected Q2 2026) to determine if the project can move from exploration to a commercially viable reserve.
- Share-Based Compensation: Monitor the impact of the $9.6M share-based payment expense on future dilution and cash flow, given the heavy reliance on equity incentives for retention.